Table 2 High dose chemotherapy regimen in the high-dose chemotherapy group (N=60)
From: Are there candidates for high-dose chemotherapy in ovarian carcinoma?
N (%) | |
|---|---|
Carboplatin AUC 18 | 12 (20) |
Cyclophosphamide 60mg/kg/d (d-3 to d-2) + melphalan 140 mg/m2 d-1 | 32 (53) |
Cycle 1: cyclophosphamide 60mg/kg/d (d-3 to d-2) + melphalan 140 mg/m² d-1 + | |
Cycle 2: thiotepa 300mg/m²/d d-3 to d-2 | 8 (13) |
Melphalan 140 mg/m² d-1 | 3 (5) |
Thiotepa 300mg/m²/d d-3 to d-2 | 1 (2) |
Cycle 1: melphalan 140 mg/m² d-1 + Cycle 2: thiotepa 300mg/m²/d d-3 to d-2 | 2 (3) |
Topotecan 7,5mg/m²/d (d-6 to d-2) | 2 (3)* |